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Abstract
The Beijing genotype of Mycobacterium tuberculosis has frequently
been found to be associated with drug resistance. Mutation anal-
ysis of the genes encoding 16S rRNA (rrs) and ribosomal protein
S12 (rpsL) revealed a high frequency (97/102; 95.1%) of altera-
tions in streptomycin-resistant M. tuberculosis isolates from
Singapore, with rpsL K43R being the most common rpsL muta-
tion (82/92; 89%), which was signiﬁcantly associated with Beijing
strains compared to non-Beijing strains (odds ratio = 10.88, 95%
conﬁdence interval = 3.48–34.1). This is the ﬁrst study to report
the association of Beijing strains with the rpsL K43R mutation in
STR-resistant M. tuberculosis isolates with de novo resistance, as
determined by clustering analysis.
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Streptomycin (STR), an aminocyclitol antibiotic, is commonly
used as an anti-mycobacterial drug. It has been shown to
interact directly with the small ribosomal subunit 16S rRNA,
interfering with translational proofreading, thereby leading to
inhibition of protein synthesis [1,2]. Mutations associated
with STR-resistance in Mycobacterium tuberculosis have been
identiﬁed in the genes encoding 16S rRNA (rrs) and ribo-
somal protein S12 (rpsL) [3,4]. Mutations in rpsL at codons
43 or 88 are more common and correlate with high levels of
resistance, whereas mutations in rrs are mainly clustered in
two loop regions around nucleotides 530 and 915 [3,5–7].
Widely varying frequencies of these mutations have been
reported, in the range 0–85% [5,8,9].
Interestingly, STR-resistance has frequently been found to
be associated with the M. tuberculosis Beijing genotype strains
in Vietnam, Russia, the UK and Singapore [10–14], but the
molecular mechanism underlying this association has not
been well elucidated.
The present study aimed to determine the spectrum and
frequency of mutations in the rpsL and rrs genes in STR-resis-
tant M. tuberculosis isolates from Singapore and to investigate
possible associations between speciﬁc mutations and spoligo-
types.
One hundred and two STR-resistant and 46 STR-suscepti-
ble M. tuberculosis isolates were analysed. The isolates were
consecutively collected between August 1994 and December
1996 by the Central Tuberculosis Laboratory, Singapore
General Hospital, tested for streptomycin susceptibility using
the BACTEC 460 radiometric method (Becton Dickinson,
Sparks, MD, USA), and analysed by IS6110 restriction frag-
ment length polymorphism (RFLP), mycobacterial inter-
spersed repetitive units-variable number of tandem repeats
(MIRU-VNTR) and spoligotyping [13]. The DNA of one iso-
late had degraded and, thus, the study included 102 rather
than 103 STR-resistant isolates [13].
The spoligotypes of the 102 STR-resistant isolates
included 81 Beijing, eight East African–Indian, two Central
Asian, four Haarlem, one Latin American–Mediterranean,
three T, and three Singapore (as designated in reference
[13]) isolates, and the 46 susceptible isolates included 22
Beijing, 12 East African–Indian, seven Haarlem, two Latin
American–Mediterranean and three T isolates. PCR and
DNA sequencing were performed as described previously
[9,15,16], except that two (rather than one) overlapping frag-
ments of the rrs gene were ampliﬁed. Differences among
groups were tested using the chi-squared test or Fisher’s
exact test and expressed as odds ratio (OR) with 95% conﬁ-
dence interval (CI).
Among the 102 STR-resistant isolates, 92 (90.2%) had
mutations in rpsL, 82 with alterations at codon 43 and ten
with alterations at codon 88 (Table 1). Five isolates (4.9%)
had mutations in rrs and ﬁve (4.9%) had wild-type alleles of
both genes (Table 1). All mutations detected were mutually
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exclusive (i.e. isolates had mutations in only one of the
genes) and multiple mutations were not observed in any
isolate. No mutations in the rpsL and rrs genes were identi-
ﬁed in any of the 46 STR-susceptible strains.
Overall, we have identiﬁed a high frequency (97/102; 95.1%)
of STR resistance- associated mutations in M. tuberculosis
isolates from Singapore, with rpsL K43R being the most
common rpsL mutation (82/92; 89%). To our knowledge, this
mutation frequency is the highest reported to date. This high
frequency might be a result of the prevalence of strains of the
Beijing family in Singapore [13]. Indeed, in other areas where
Beijing strains are common (e.g. Japan and Latvia), more than
78% of STR-resistant isolates had rpsL and rrs gene mutations
[5,8], whereas, in India, where Beijing strains are uncommon,
no resistance-associated mutations were identiﬁed in rpsL and
rrs in any of the 14 STR-resistant isolates [9].
The K88R, K88Q and K88T mutations in rpsL were
detected in the isolates from Singapore in the present study.
These mutations are uncommon, with K88R being reported
in Japan, Germany and Sierra Leone, and K88Q being
reported only in Japan and Germany [5–7,17,18].
It is important to differentiate between strains with
de novo resistance and those with transmitted resistance
because the latter constitute a confounder when determining
whether Beijing strains have a particular propensity to
acquire mutations, particularly because Beijing strains are
more transmissible [13,14].
Cluster analysis was used to identify epidemiologically
related M. tuberculosis isolates [13,19]. Isolates with identical
IS6110 RFLP, MIRU-VNTR, spoligotype, drug resistance phe-
notype and drug resistance mutation pattern were deﬁned as
belonging to a transmission cluster, with one source isolate
assumed in each cluster and the remaining isolates in a
cluster assumed to be a result of recent transmission [13].
Eleven such transmission clusters (ten Beijing strain clusters
and one Singapore strain cluster) were identiﬁed, which
comprised 27 isolates [13]. Therefore, 16 STR-resistant iso-
lates were transmitted, and 75 non-clustered isolates and 11
source isolates had likely developed STR-resistance de novo.
Among the 86 strains with possible de novo resistance
(Table 1), 66 were Beijing strains (Table 2). Beijing strains had a
higher frequency (88.0%) of the rpsL K43R mutation compared
to non-Beijing strains (40%) (OR = 10.88, 95% CI = 3.48–
34.1). Conversely, the frequencies of the rpsL codon 88 muta-
tions (4.5% vs. 35%; OR = 0.09, 95% CI = 0.02–0.36) and the
rrs mutations (3% vs. 15%; OR = 0.18, 95% CI = 0.03–0.97)
were less common in Beijing strains than in non-Beijing strains.
Speciﬁc resistance-conferring mutations have been associ-
ated with certain spoligotypes [11,20]. A strong association
was observed between Beijing strains and the rpsL K43R
mutation (OR = 10.88), concurring with an earlier smaller
study of 12 STR-resistant Beijing clinical isolates from the
UK [11]. In addition, we have found this association in
TABLE 1. Distribution of mutations in the rpsL and rrs genes according to genotypes in 102 streptomycin-resistant
Mycobacterium tuberculosis isolates
Spoligotype
rpsL mutants (n = 92) rrs mutants (n = 5)





Beijing 48, [Clustered = 25]a 3 – – 2 – 3 56 [+25] = 81
T 2 – – – – 1 – 3
EAI 3 2 – – 1 1 1 8
Haarlem 1 1 – 1 – – 1 4
CAS – 2 – – – – – 2
LAM 1 – – – – – – 1
Singapore [Clustered = 2]a – 1 – – – – 1 [+2] = 3
Total 55 [+27] = 82 8 1 1 3 2 5 102
Numbers in square parenthesis indicate the number of isolates with identical genotypes to other isolates, based on IS6110 restriction fragment length polymorphism, myco-
bacterial interspersed repetitive units-variable number of tandem repeats, and spoligotyping.
WT, wild-type; Beijing, Beijing genotype; T, T genotype; EAI, East African–Indian genotype; Haarlem, Haarlem genotype; CAS, Central Asian genotype; LAM, Latin American–
Mediterranean genotype; SG, Singapore genotype.
aOf a total of 102 isolates, there were 27 isolates in 11 clusters [13]. The number of strains with de novo resistance = 102 ) (27 ) 11) = 86. We assumed that there was
one source isolate in each cluster, with the remaining isolates in a cluster being a result of recent transmission.
TABLE 2. Frequencies of streptomycin-resistance associated
rpsL and rrs mutations in 86 Mycobacterium tuberculosis
Beijing and non-Beijing strains with acquired resistance
Beijing Non-Beijing
rpsL codon 43 mutation 58 (88) 8 (40)
rpsL codon 88 mutations 3 (4.5) 7 (35)
rrs mutations 2 (3) 3 (15)
Wild type 3 (4.5) 2 (10)
Total 66 (100) 20 (100)
Data are presented as n (%).
288 Clinical Microbiology and Infection, Volume 16 Number 3, March 2010 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 287–301
strains with de novo resistance. Hence, the ﬁndings obtained
in the present study suggest that the rpsL K43R mutation in
STR-resistant M. tuberculosis may not occur independently
and randomly in different genotype strains. Instead, it is
genotype-related (i.e. the Beijing genotype has a particular
propensity to acquire the rpsL K43R mutation) and this
molecular mechanism may account for the high frequency of
Beijing strains among STR-resistant isolates.
In conclusion, the high frequency of mutations in rpsL and
rrs in STR-resistant isolates from Singapore suggests that tar-
geted mutation screening could be feasible for the rapid
determination of STR resistance. Furthermore, the present
study provides evidence of the association between the rpsL
K43R mutation and STR-resistant strains of the Beijing geno-
type. Further studies to determine whether Beijing strains
with the rpsL K43R mutation have increased transmissibility
and/or virulence are warranted.
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